LAUSR

Dear Editor, I read with interest the original study by Al-Mamri et al. published in the November 2019 issue of SQUMJ.1 Based on the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), the authors estimated the prevalence of autism spectrum disorder (ASD) among Omani children and compared it with Oman’s estimate from 2011. They found that ASD prevalence was 20.35 per 10,000 children, which was 15-fold higher than the estimate from 2011 (1.4 cases per 10,000 children).1 They attributed this increased prevalence to many factors, namely improvement in the diagnostic services, increased awareness of ASD, improved screening programmes and changes in the criteria of diagnosing ASD.1 However, the last explanatory factor should be taken cautiously. My assumption is based on the following point: Al-Mamri et al. employed the DSM-5 criteria in their study methodology while the ASD estimate from 2011 was based on DSM-IV criteria.1,2 It is noteworthy that compared to the DSM-IV criteria, evaluation of the DSM-5 criteria revealed good sensitivity and excellent overall specificity. The specificity and sensitivity were noticed to be strongest for children meeting the DSM-IV criteria for ASD, but poor for those meeting criteria for pervasive developmental disorder and Asperger's disorder.3 Older age, higher intelligence quotient, female gender and less evident ASD manifestations were noted to be correlated with higher discordance.3 Importantly, DSM-5 criteria could impact which children fulfil the ASD diagnostic criteria, that ultimately influences the access to healthcare services.4 Accordingly, the adoption of the DSM-5 criteria would likely lower the ASD prevalence estimate compared to DSM-IV diagnostic criteria.5 Surprisingly, ASD prevalence reported by Al-Mamri et al. was much greater than that reported in 2011 despite the variation in the version of ASD diagnostic criteria.1 With the notion that the studied population in Al-Mamri et al.’s study involved a hospitalbased sample, I presume that the worryingly high reported ASD prevalence (20.35 per 10,000 children) represents only the tip of the iceberg of a sizable paediatric health problem in Oman.1 Therefore, I agree with Al-Mamri et al.’s recommendation of implementing strategic action, including registry, screening and rehabilitations programmes that are deemed justifiable to contain a further spike in ASD prevalence among the Omani paediatric population.